Skip to main content
Calixar partners with Regeneron on antibody research
4/30/2019

Regeneron Pharmaceuticals and Calixar have entered a partnership, the value of which is undisclosed, focused on research into antibodies in various therapeutic fields. The collaboration gives Regeneron exclusive licensing rights to Calixar's native membrane protein stabilization technology.

Full Story: